The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 256-265

Karger

Access to resources Recommend Favorite

Treatment with Simvastatin in Patients with Alzheimer’s Disease Lowers Both α- and β-Cleaved Amyloid Precursor Protein

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 1, 2003-05 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Reduced Expression of Amyloid Precursor Protein, Presenilin-1 and rab3a in Cortical Brain Regions in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 243-250

Karger

Access to resources Recommend Favorite

Current Smoking and Response to Cholinesterase Inhibitor Therapy in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 1, 2004-12 ,pp. : 11-14

Karger

Access to resources Recommend Favorite